ArisGlobal held a mid-January webcast “From Good to Great: The Benefits of Unified Clinical and Regulatory Data Management Strategy”
with the goal of examining the challenges involved, benefits to be gained, requirements of unified regulatory and clinical business processes, and recommendations for taking the next steps forward. ArisGlobal presenters, Vitthal Gouri,
Associate VP, Clinical Solutions, and Pratyusha Pallavi
, Associate Director, Regulatory Product Management, shared their respective expertise to advance the viewpoint that it’s time to explore the significant gains to be achieved from this unification with the right approach, advanced platform, cross-department participation and commitment across clinical, regulatory and IT departments.
The webcast audience, comprising of strong representation across clinical, regulatory and IT, responded to polling questions that helped throw light on the current reality facing companies seeking to undertake the mammoth task of cross departmental unification.
Beginning with the polling question on “What has been your biggest challenge in relation to Clinical and Regulatory technologies?
”, the attendee polling results across the five possible responses clearly showed that the regulatory and clinical departments are grappling with a multi-faceted challenge. The results showed nearly equal strength except for one. Laborious Upgrades and Validation Cycles
ranked highest with 25%, but the lack of a Single Source of Truth
, Complexity of Desired Process Automation
, and Data Quality Not Available in Real-Time
all tied at 21%. Trailing last at 13% was Lack of Common Terminology